Related Experiment Video
Updated: Nov 9, 2025
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Management of Severe Atopic Dermatitis in Pediatric Patients
Jennifer B Mancuso1, Stephanie S Lee2, Amy S Paller3
1Department of Dermatology, University of Michigan Medical School, Ann Arbor, Mich.
Insights
Optimizing severe atopic dermatitis management in children is crucial. This guide details topical, phototherapy, and systemic treatments, plus nonpharmacologic interventions for better quality of life.
Area of Science:
- Dermatology
- Pediatrics
- Immunology
Background:
- Atopic dermatitis (AD) is a prevalent chronic inflammatory skin condition affecting 12% of children globally.
- Effective management of severe pediatric AD is vital for reducing inflammation, itch, sleep issues, and comorbidities, thereby improving quality of life.
- Longitudinal severity assessment is key for evaluating treatment response in pediatric AD, differing between clinical practice and trials.
Purpose of the Study:
- To provide guidance on optimizing the management of severe atopic dermatitis in pediatric patients.
- To outline the appropriate use of various therapeutic options for severe pediatric AD.
- To offer practical recommendations for nonpharmacologic interventions in clinical settings.
Main Methods:
- Review of current literature on atopic dermatitis treatments for pediatric populations.
- Description of pharmacologic interventions including topical medications, phototherapy, traditional immunosuppressants, biologics, and small molecule inhibitors.
- Inclusion of evidence-based recommendations for nonpharmacologic management strategies.
Main Results:
- Detailed explanation of when and how to utilize diverse treatment modalities for severe pediatric atopic dermatitis.
- Emphasis on the importance of a comprehensive approach combining medical and nonmedical interventions.
- Highlighting the differences in severity evaluation between clinical practice and research settings.
Conclusions:
- Optimized management strategies are essential for improving outcomes in children with severe atopic dermatitis.
- A multi-faceted treatment approach, including pharmacologic and nonpharmacologic methods, is recommended for clinical practice.
- Continuous evaluation of disease severity is critical for effective long-term care and therapeutic success.
Abstract:
Atopic dermatitis is a common, chronic inflammatory skin disorder, present in about 12% of children worldwide. Optimizing management of severe atopic dermatitis in pediatric patients is critical to reduce signs of inflammation, alleviate pruritus and sleep disturbance, minimize the development and/or impact of comorbidities, and improve the patient and caregiver's quality of life. Evaluating the longitudinal severity of pediatric atopic dermatitis is an important component of measuring therapeutic response and long-term management, and is different in clinical practice versus clinical trials. This article describes when and how to use different treatments for pediatric patients with severe atopic dermatitis, including topical medications, phototherapy, and systemic medical therapies (traditional immunosuppressants, biologics, and small molecule inhibitors). It also provides recommendations useful in clinical practice for nonpharmacologic interventions for pediatric patients with severe atopic dermatitis.
More Related Videos
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
06:47Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
Related Concept Videos
01:30Asthma-IV: Nursing Management
First, in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:29Drug Dosing: Infants and Children